Investors / Belgium / V-Bio Ventures
V-Bio Ventures
Venture capital · Belgium · Europe
V-Bio Ventures is a life science venture capital fund that co-creates startups and invests in early- to mid-stage companies. It focuses on therapeutics, including drug discovery and drug development, and has a preferred relationship with the Belgium-based VIB research institute.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordslife sciencestherapeuticsdrug discoverydrug developmentbiotech
Your fit with V-Bio Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsV-Bio Ventures lists 20 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (81%) and AI & Machine Learning (19%). 46% of its companies are based in Belgium. It invests most often alongside PMV, Agri Investment Fund and Fund+.
Counts come from funding rounds that name V-Bio Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not V-Bio Ventures' whole history. Rounds on record name 1 company; its own site lists 20. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 100% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 51th | 20 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 63th | 5% of companies confirmed by a round |
| Sector focus | 93th | 81% in its largest sector |
| Reach | 84th | 6 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| PMV | 6 |
| Agri Investment Fund | 4 |
| Fund+ | 4 |
| Kurma Partners | 4 |
| Qbic | 3 |
| VIVES | 3 |
| AdBio partners | 2 |
| Asabys Partners | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers20100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 81% | 15% |
| AI & Machine Learning | 19% | 18% |
Co-investor network
who it backs companies with, and who they back togetherCompare V-Bio Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with V-Bio Ventures| Date | Company | Stage |
|---|---|---|
| 24 Mar 2025 | Series A |
Round details for V-Bio Ventures
Amounts, full round histories and every co-investor in V-Bio Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
20 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Agomab is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for fibro-inflammatory diseases. | Healthcare & Biotech | Portfolio page | ||
| Animab is a biotechnology company that supports livestock health through proprietary technology | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Arc Therapeutics is a biopharmaceutical company advancing medicines for CNS patient populations | Healthcare & Biotech | Portfolio page | ||
| Astrivax Therapeutics develops immunotherapies to eliminate viruses that can cause cancer | Healthcare & Biotech | Portfolio page | ||
| ATB Therapeutics develops novel therapeutic solutions for patients with cancer and auto-immune disease using antibody payload technology. | Healthcare & Biotech | Portfolio page | ||
| Augustine Therapeutics develops novel HDAC6 inhibitors for the treatment of chronic diseases | Healthcare & Biotech | Mar 2025Series A | Page + round | |
| Avidicure develops antibodies for patients with oncology and autoimmune diseases | Healthcare & Biotech | Portfolio page | ||
| Biodol Therapeutics develops first-in-class compounds for the treatment of chronic pain. | Healthcare & Biotech | Portfolio page | ||
| Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare ocular and CNS diseases. | Healthcare & Biotech | Portfolio page | ||
| Confo Therapeutics is a clinical-stage company committed to identifying and accelerating novel medicines for metabolic and endocrine diseases. | Healthcare & Biotech | Portfolio page | ||
| Corteria Pharmaceuticals is a privately held company developing first-in-class drugs for indications of high unmet medical need, such as obesity, heart failure subpopulations and autosomal dominant polycystic kidney disease | Healthcare & Biotech | Portfolio page | ||
| ExeVir Bio develops novel antibody therapies to prevent and treat infectious diseases. | Healthcare & Biotech | Portfolio page | ||
| Flindr Therapeutics develops a pipeline of first-in-class small molecule inhibitors for the precision treatment of cancer. | Healthcare & Biotech | Portfolio page | ||
| Muna Therapeutics discovers and develops therapies that slow or stop devastating neurodegenerative diseases including Alzheimer’s and Parkinson’s. | Healthcare & Biotech | Portfolio page | ||
| Orionis Biosciences develops novel precision medicines to fight cancer | Healthcare & Biotech | Portfolio page | ||
| Protealis specializes in local plant protein legumes for Europe, offering high-performance legume seeds to farmers | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| RootWave uses electricity to kill weeds and their roots | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| Sibylla Biotech develops small molecule drug candidates that target proteins before they become undruggable using its proprietary technology platform. | Healthcare & Biotech | Portfolio page | ||
| STEP Pharma is developing a novel drug called dencatistat for the treatment of cancer | Healthcare & Biotech | Portfolio page |
About this data
site last read 8 Nov 2026- Site
- v-bio.ventures
- Last read
- 8 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 24 Mar 2025
- Companies checked
- 20
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get V-Bio Ventures' profile as data
Pull V-Bio Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/v-bio.ventures
# also
GET /v1/firms/v-bio.ventures/portfolio
GET /v1/firms/v-bio.ventures/coinvestors
GET /v1/firms/v-bio.ventures/news